Vol. 1, Issue 1, Part A (2017)

Material and Methods:A cross-sectional study was done on 100 patients who went to the Department of Ophthalmology, Srilakshmi Narayana Institute of Medical Sciences in Puducherry, India, from January 2016 to December 2016. The patients were chosen at random and the study was done using repeated sampling. People over the age of eighteen with type 2 diabetes mellitus who did not have peripheral neuropathy and had their HbA1c levels checked in the last two months were included in the study.

Results:After ruling out other possible causes of neuropathy, diabetic polyneuropathy can be identified when a person has symptoms and/or signs of peripheral nerve degeneration. Nerve conduction tests, especially those that look at nerves in the lower limbs, show problems that support this diagnosis even more. Several tools have been created to quickly and fully check for symptoms and signs of DPN. The TCNS is a valid and accurate clinical assessment tool that is often used in therapy and study. It is one of many scales that are used to describe and rate the severity of neuropathy. The current study used TCNS to divide neuropathy into three separate groups: neuropathy that wasn't present, low to moderate neuropathy, and severe neuropathy. People with DPN may have a variety of pathophysiology that cause their symptoms.

Conclusion:The study's results show that the thicknesses of the inferior and temporal parapapillary regions, as well as the overall thickness of the retinal nerve fiber layer, can help predict how neuropathy will get worse in people with type 2 diabetes.